KnowHow: The FDB Blog

Healthcare Supply chain

Repair Hospital Supply Chain Data Breaks to Protect Patient Safety

Corporate Perspective, Transformational Change, Information Systems
Monday, February 5, 2018
by Lee Ann McWhorter

Today’s medical device data is far more likely to be inaccurate, unclear, and unreliable. And that’s entirely unacceptable when you consider the vast range of users who rely on this knowledge to identify, source, manage, document, track, and bill for millions of device options. Read More

Artificial Intelligence in Health IT – Catalyst for Change?

Corporate Perspective, Information Systems, Transformational Change
Wednesday, January 3, 2018
by Josh Young

We recently interviewed FDB's Director of Software Engineering Joshua Young about the application of artificial intelligence in healthcare. What follows are highlights from that interview. Read More

FDA's Biosimilar ID Requirements Fly in the Face of Cost-Cutting Aspirations

Corporate Perspective, Government, Standards
Friday, November 10, 2017
by Tom Bizzaro, RPh

Curiously, the FDA seems to be undercutting its own cost savings efforts through its support of a rule that would require unique non-proprietary names with four-character suffixes for biosimilar products. The problem is this proposed naming convention is simply not necessary and could do more harm than good. Read More

Welcome to Drug Knowledge


What if drug data was more than just data? > Visit the Media Centre for more videos.

Media Centre >